A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese Volunteers
Clinical trial NCT03887221 · COMPLETED
Trial details
- NCT number
- NCT03887221
- Sponsor
- Zambon SpA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-21
- Primary completion
- 2021-08-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.